• SENSEX
    NIFTY 50
Earnings

Allergan lifts earnings target, says no drug price hikes this year

Updated : July 26, 2018 10:05 PM IST

The remarks about curbing price hikes echoed sentiment from Allergan's peers including Pfizer, Merck and Novartis, as US President Donald Trump's administration intensifies efforts to tackle escalating healthcare costs.
Sales of Botox, as well as sales from Allergan's second most important drug, Restasis, exceeded Wall Street expectations by a comfortable margin in the second quarter ended June 30.
Investors have called for changes at the top at Allergan, following a series of setbacks to its pipeline of potential new drugs and a string of acquisitions that have taken the company's debt pile past $25 billion.
Allergan lifts earnings target, says no drug price hikes this year
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV